IMIS | Flanders Marine Institute
 

Flanders Marine Institute

Platform for marine research

IMIS

Publications | Institutes | Persons | Datasets | Projects | Maps
[ report an error in this record ]basket (0): add | show Printer-friendly version

Conjugation of isometamidium chloride to antibodies and the use of the conjugate against the haemoflagellate, Cryptobia salmositica Katz, 1951: an immuno-chemotherapeutic strategy
Ardelli, B.F.; Woo, P.T.K. (2001). Conjugation of isometamidium chloride to antibodies and the use of the conjugate against the haemoflagellate, Cryptobia salmositica Katz, 1951: an immuno-chemotherapeutic strategy. J. Fish Dis. 24: 439-451
In: Journal of Fish Diseases. Blackwell Science: Oxford; London; Edinburgh; Boston; Melbourne. ISSN 0140-7775, more
Peer reviewed article  

Available in  Authors 

Keyword
    Marine

Authors  Top 
  • Ardelli, B.F.
  • Woo, P.T.K.

Abstract
    The trypanocidal drug isometamidium chloride (Samorin) was conjugated to polyclonal and monoclonal antibodies produced against the pathogenic haemoflagellate Cryptobia salmositica. Under in vitro conditions the unconjugated drug normally accumulates rapidly in the kinetoplast in the parasite; however, once it was conjugated to antibodies (either polyclonal or monoclonal) it was found throughout the parasite. Isometamidium conjugated to polyclonal antibodies lysed C. salmositica under in vitro conditions, but parasites were not agglutinated. In contrast, isometamidium conjugated to monoclonal antibodies (against a 200 kDa surface membrane glycoprotein) did not lyse C. salmositica, but parasites were agglutinated. Because of the low efficacy of the monoclonal conjugate against the parasite in vitro, its cryptobiocidal effect was not evaluated further. The infectivity of C. salmositica (incubated either in culture medium or whole blood) was reduced in fish after in vitro exposure to isometamidium conjugated to polyclonal antibodies. Parasitaemias were reduced in infected chinook salmon, Oncorhynchus tshawytscha, after treatment with isometamidium conjugated to polyclonal antibodies.

All data in IMIS is subject to the VLIZ privacy policy Top | Authors